药物对比
Alogliptin vs Nateglinide
Alogliptin vs Nateglinide治疗2型糖尿病。Alogliptin是每日一次的DPP-4抑制剂，与餐时服用的格列奈类药物Nateglinide相比，低血糖风险更低。
此页面暂无可用的对比维度。
临床背景
This comparison is relevant when selecting between a DPP-4 inhibitor and a meglitinide for managing type 2 diabetes, especially considering dosing frequency and hypoglycemia risk.
结论
Alogliptin is typically preferred over Nateglinide in modern type 2 diabetes treatment for its ease of use and safety advantages.
全部药物对比